blog | AgomAb

Skip to content

Login

Login

Subscribe to our Newsletter

Go Back to Home

Go Back to Blog

2026, Once Upon a Farm, AgomAb, SpyGlass Pharma

End-of-Day IPO Review: Selective Strength, No Broad Confirmation - February 6, 2026

$Picture of {{ content.blog_author.display_name }}$ Dave Berlin

Feb 6, 2026 4:21:49 PM

Once Upon a Farm PBC (OFRM)

IPOs, Nasdaq, 2026, AgomAb

AgomAb Therapeutics Sets Terms for IPO as Fibrosis-Focused Biotech Advances Clinical Pipeline

$Picture of {{ content.blog_author.display_name }}$ Eric Friedman

Jan 30, 2026 2:56:35 PM

AgomAb Therapeutics NV has set terms for its initial public offering, positioning the fibrosis-focus...

Subscribe to our Newsletter

NONE OF THE CONTENT PUBLISHED ON THE WEBSITE OR MOBILE APP CONSTITUTES A RECOMMENDATION, SOLICITATION, ENDORSEMENT, OR OFFER BY IPO PROPHET™ OR ITS AFFILIATES TO BUY OR SELL ANY SECURITIES, FUTURES, OPTIONS, OR OTHER FINANCIAL INSTRUMENTS, OR PROVIDE ANY INVESTMENT ADVICE OR SERVICE.

Copyright © 2025